Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia

Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia

US Patent 10973773 · Granted Apr 13, 2021

Estimated economic value: $2,904,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ultra-pure agonists of guanylate cyclase C, method of making and using same2024
Dactinomycin compositions and methods for the treatment of myelodysplastic syndr2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same2021
Agonists of guanylate cyclase and their uses2021
Formulations of milciclib and therapeutic combinations of the same for use in th2020
Ultra-pure agonists of guanylate cyclase C, method of making and using same2020
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disor2020
Anti-CD3 antibody formulations2020
Formulations and methods for treating ulcerative colitis2020
Agonists of guanylate cyclase and their uses2020